相关实验视频
Updated: May 20, 2025
07:29
Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
7.5K
重定位佩林多普里尔用于减轻大鼠中甲基酸诱导的肝毒性
Hanan Abdelmawgoud Atia1, Hemat A Elariny1, Marwa H Abdallah2
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia.
Pharmaceuticals (Basel, Switzerland)
|March 27, 2025
概括
佩林多普里尔在保护肝脏免受甲三甲酸诱导的损伤方面表现有前途. 这项研究发现,通过降低大鼠的炎症,亡和纤维化,布有效地减轻了肝损伤.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
背景情况:
- 甲基 (MTX) 是一种重要的抗癌和免疫调节药物,但其使用受到潜在的肝毒性限制.
- 目前对MTX诱导的肝损伤的治疗方法不足,需要新的治疗策略.
- 胺- ангиотензин系统在MTX肝毒性中的作用表明,胺- ангиотензин转化酶抑制剂的潜在益处,如perindopril.
研究的目的:
- 评估大鼠模型中对甲三甲酸诱导的肝毒性进行保护性作用.
- 阐明潜伏的潜在治疗作用背后的分子机制.
主要方法:
- 使用雄性Wistar大鼠建立了甲状腺胺诱导的肝毒性模型.
- 为了评估生化和形态变化,通过口服给予不同剂量的印布里尔.
- 研究了与炎症,亡,纤维化和自相关的关键分子通路.
主要成果:
- 佩林多普里尔的剂量取决于改善了食物摄入量和恢复肝细胞功能.
- 它增强了抗氧化剂防御机制,减少了肝炎,亡和纤维化.
- 佩林多普里尔促进了AMPK/mTOR驱动的自,抵消了甲醇的毒性作用.
结论:
- 佩林多普利尔在老鼠中显示出显著的肝保护作用,可以防止甲状腺酸诱导的肝损伤.
- 它通过调节氧化应激,炎症,亡,纤维化和自途径来起作用.
- 佩林多普里尔是一种潜在的治疗药物,可以缓解甲醇酸相关的肝毒性.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
354
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
139
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
139
01:11Renal Failure: Dose Adjustments
50
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
50
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
118
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
118
01:26Enhanced Elimination of Poison
467
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
467